Stephen Huhn
Director Técnico/Científico/I+D en CONTINEUM THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Stephen L.
Huhn is currently the Chief Medical Officer & SVP-Clinical Development at Contineum Therapeutics, Inc. He previously worked as the Chief Medical Officer & VP-CNS Clinical Research at StemCells, Inc. from 2014 to 2015.
Prior to that, he held the position of Associate Professor-Neurosurgery at Stanford University.
Dr. Huhn obtained his doctorate degree from the University of Arizona in 1987.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/05/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Stephen Huhn
| Empresas | Cargo | Inicio |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2020 |
Antiguos cargos conocidos de Stephen Huhn.
| Empresas | Cargo | Fin |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Director Técnico/Científico/I+D | - |
| Stanford University | Corporate Officer/Principal | - |
Formación de Stephen Huhn.
| University of Arizona | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Huhn
